TPT Global Tech (OTC: TPTW), a provider of telecommunications, medical technology, media content for domestic and international syndication as well as technology solutions, today announced the release of two new products and services for use at its TPT Med Tech division. These include its “QuikLAB” App, designed for use in monitoring patient testing and vaccination history, and its “QuikPASS” Mobile App. QuikPASS is designed to allow entrance to any facility or country based on patient test and vaccination results on a real-time basis worldwide. The QuikPASS App will be offered free of charge to U.S. and international consumer markets. TPT Global Tech will license the QuikLAB network to global companies, partner labs and testing organizations for a monthly licensing fee and a per COVID-19 test fee. “We believe that our technology platforms will prove to be a great weapon and asset in the fight against COVID-19 in the United States and in international communities around the world,” said TPT Global Tech CEO Stephen J. Thomas III. “It is our commitment to continue delivering innovative solutions to help in the fight against COVID-19.”
To view the full press release, visit https://ibn.fm/zPXX3
About TPT Global Tech Inc.
Based in San Diego, California, TPT Global Tech is a technology-based company with divisions providing telecommunications, medical technology and product distribution, and media content for domestic and international syndication as well as technology solutions. TPT Global Tech offers Software as a Service (“SaaS”), Technology Platform as a Service (“PaaS”) and cloud-based Unified Communication as a Service (“UCaaS”). The company offers carrier-grade performance and support for businesses over its private IP MPLS fiber and wireless network in the United States. TPT’s cloud-based UCaaS services allow businesses of any size to enjoy all the latest voice, data, media and collaboration features in available in today’s global technology markets. TPT Global Tech also operates as a master distributor for Nationwide Mobile Virtual Network Operators (“MVNO”) and Independent Sales Organizations (“ISO”) as a master distributor for prepaid cell phone services, mobile phones cell phone accessories and global roaming cell phones.
For more information, visit the company’s website at www.TPTGlobalTech.com.
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork